KCNIP3 Human

Kv Channel Interacting Protein 3 Human Recombinant
Cat. No.
BT17722
Source
Escherichia Coli.
Synonyms
Calsenilin, A-type potassium channel modulatory protein 3, DRE-antagonist modulator, Kv channel-interacting protein 3, KCNIP3, CSEN, DREAM, KCHIP3, MGC18289.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

KCNIP3 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 276 amino acids (1-256 a.a.) and having a molecular mass of 31.4kDa. The KCNIP3 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
KCNIP3, a member of the voltage-gated potassium (Kv) channel-interacting protein family, belongs to the recoverin branch of the EF-hand superfamily. This family comprises small calcium-binding proteins with EF-hand-like domains. KCNIP3 acts as a calcium-regulated transcriptional repressor and interacts with presenilins. Mutations in presenilin genes have been linked to Alzheimer's disease.
Description
Recombinant human KCNIP3, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein, fused with a 20 amino acid His tag at its N-terminus, consists of 276 amino acids (residues 1-256) and has a molecular weight of 31.4 kDa. Purification of KCNIP3 is achieved using proprietary chromatographic methods.
Physical Appearance
Sterile, colorless solution, filtered for purity.
Formulation
The KCNIP3 solution is provided at a concentration of 1 mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 10% glycerol, 2mM DTT, and 0.1M NaCl.
Stability
For short-term storage (2-4 weeks), the solution can be stored at 4°C. For extended storage, freezing at -20°C is recommended. To ensure optimal stability during long-term storage, consider adding a carrier protein (0.1% HSA or BSA). Repeated freezing and thawing cycles should be avoided.
Purity
Purity exceeds 90.0%, as determined by SDS-PAGE analysis.
Synonyms
Calsenilin, A-type potassium channel modulatory protein 3, DRE-antagonist modulator, Kv channel-interacting protein 3, KCNIP3, CSEN, DREAM, KCHIP3, MGC18289.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MQPAKEVTKA SDGSLLGDLG HTPLSKKEGI KWQRPRLSRQ ALMRCCLVKW ILSSTAPQGS DSSDSELELS TVRHQPEGLD QLQAQTKFTK KELQSLYRGF KNECPTGLVD EDTFKLIYAQ FFPQGDATTY AHFLFNAFDA DGNGAIHFED FVVGLSILLR GTVHEKLKWA FNLYDINKDG YITKEEMLAI MKSIYDMMGR HTYPILREDA PAEHVERFFE KMDRNQDGVV TIEEFLEACQ KDENIMSSMQ LFENVI.

Product Science Overview

Structural Properties

KChIP3 is encoded by the KCNIP3 gene and shares high sequence similarity with other KChIP family members, including KChIP1, KChIP2, and KChIP4 . The protein consists of a conserved C-terminal core domain and an N-terminal region that undergoes diverse post-translational modifications, determining its subcellular localization .

Expression Patterns and Tissue Distribution

KChIP3 is predominantly expressed in the brain and heart, where it plays a crucial role in maintaining the excitability of neurons and cardiomyocytes . It is also found in other tissues, including the endocrine and immune systems .

Biological Functions

KChIP3 serves multiple biological functions:

  1. Regulation of Kv4 Channels: KChIP3 binds to the N-terminus of Kv4 channel α-subunits, promoting their translocation to the cell membrane, accelerating voltage-dependent activation, and slowing the recovery rate of inactivation .
  2. Transcriptional Repression: KChIP3 acts as a calcium-regulated transcriptional repressor by binding to the downstream regulatory element (DRE) on the promoters of target genes . This function is implicated in the regulation of pain, memory, endocrine, immune, and inflammatory reactions .
  3. Interaction with Presenilins: KChIP3 interacts with presenilins, which are proteins implicated in Alzheimer’s disease .
Modes of Action

KChIP3 modulates the fast inactivating-Kv4 currents by regulating the surface protein expression and gating properties of Kv4 channels . It also acts as a transcription factor to repress the expression of genes involved in circadian regulation .

Regulatory Mechanisms

The activity of KChIP3 is regulated by calcium levels. When calcium binds to the EF-hand domains of KChIP3, it undergoes a conformational change that allows it to interact with target proteins and DNA .

Pathological Roles

Altered expression of KChIP3 has been implicated in several neurological and cardiovascular diseases:

  • Alzheimer’s Disease: Increased expression of KChIP3 is observed in Alzheimer’s disease .
  • Amyotrophic Lateral Sclerosis (ALS): Elevated levels of KChIP3 are found in ALS .
  • Epilepsy and Huntington’s Disease: Decreased expression of KChIP3 is associated with these conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.